DCVC

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Climate tech · Jan 1, 2026

DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.

Recorded funding activity

TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.

Sources
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$134M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Climate tech1
Defense tech1

By country

United States2

Rounds

2 in this selection
Rainmaker

Rainmaker develops cloud-seeding technology and atmospheric research tools to increase freshwater supply.

$100MSeries B
Participant
Chariot Defense

Chariot Defense develops power-distribution systems for military use.

$34MSeries A
Role not disclosed